Exelixis (EXEL) PT Lowered to $31 at RBC Capital
RBC Capital analyst Kennen MacKay lowered the price target on Exelixis (NASDAQ: EXEL) to $31.00 (from $34.00) while maintaining a Outperform rating.
RBC Capital analyst Kennen MacKay lowered the price target on Exelixis (NASDAQ: EXEL) to $31.00 (from $34.00) while maintaining a Outperform rating.